Sunflower Therapeutics Gets First Milestone Payment from SK Bioscience Read More » September 18, 2025
Ascletis Reports ASC30 Half-Life of 36 Days, Enabling Once‑Monthly Dosing Read More » September 9, 2025
Glenmark Starts Phase 3 Trial of Envafolimab for Stage III Non-Small Cell Lung Cancer Read More » September 8, 2025
Trusted by Leading Cancer Centers to Solve Oncology’s Information Overload, Triomics Raises $22 million to Accelerate Adoption
Coral Raises $12.5m to Automate Healthcare’s Back Office by Working With, Not Against, the Fax Machine
